Industry News - BioPharm International


Industry News
The latest news about industry suppliers, business activities, people.

FDA Releases First-Ever Purple Book for Biosimilar Characterization

September 26, 2014

The Purple Book will list biologic and biosimilar products and will serve as a guide for interchangeability.

USP Supports WHO Biologics Naming Proposal

September 25, 2014

USP expresses its support for a consensus-based global approach to the naming of biologics.

PCI Acquires Biotec

September 19, 2014

PCI's acquisition of Biotech Services International expands the packaging services provider's presence in Europe.

European Commission Grants Lilly and Boehringer Ingelheim's Insulin Glargine Product Marketing in EU

September 12, 2014

European Commission granted the first biosimilar insulin to receive regulatory approval in Europe.

BioTime Subsidiary Partners with Cancer Research UK in Clinical Trial of Lung Cancer Treatment

September 12, 2014

Asterias Biotherapeutics, Cancer Research UK, and Cancer Research Technology partner for clinical trial of immunotherapy vaccine for the treatment of lung cancer.

ProBioGen Plans Expansion

September 9, 2014

ProBioGen, a biopharmaceutical drug manufacturer in Berlin, spends ?20 million to double its workforce.

University of Toronto Announces Collaboration with Janssen and Johnson & Johnson Innovation

September 8, 2014

Three-year agreement will support research on treatments for major brain disorders in Neuroscience Catalyst project.

Catalent Adds Prefilled Syringe Line for Clinical Trial Supplies

September 4, 2014

Catalent's addition of an automated prefilled syringe clinical packaging line at its Philadelphia facility will support its work with Eli Lilly.

Pfizer Announces Approval of ELELYSO in Treatment of Type 1 Gaucher Disease

August 29, 2014

Pfizer announced that FDA approved ELELYSO for treatment of Type 1 Gaucher disease in adult and pediatric patients.



Click here